IMA earnings: a negative outcome, -13.6%

On May 13, 2021, ImageneBio, Inc. reached its earnings. The result was a negative outcome, and the stock moved -13.6% in the window around the event. It had already run +24.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.